Abbott Laboratories;Hvidovre Hospital;University of Copenhagen
发明人:
申请号：
EP15757396.5
公开号：
EP3183578B1
申请日:
2015.08.21
申请国别(地区):
EP
年份:
2020
代理人:
摘要：
Provided are methods of diagnosing high risk adenomas or colorectal cancer by detecting the presence and/or amount of at least three biomarkers of CRC in a sample from a subject. The methods and biomarkers may be used to develop an accurate prognosis for a patient having CRC or at risk of having CRC or accurately diagnose a subject having or at risk of having CRC. The methods and biomarkers may be used to identify and/or classify a patient as a candidate for further CRC screening and/or CRC treatment therapy.
